These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 19027483)

  • 21. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].
    Fukuoka M; Yano S; Giaccone G; Tamura T; Nakagawa K; Douillard JY; Nishiwaki Y; Vansteenkiste J; Kudoh S; Rischin D; Eek R; Horai T; Noda K; Takata I; Smit E; Averbuch S; Macleod A; Feyereislova A; Dong RP; Baselga J
    J Clin Oncol; 2003 Jun; 21(12):2237-46. PubMed ID: 12748244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania.
    Veronese ML; Algazy K; Bearn L; Eaby B; Alavi J; Evans T; Stevenson JP; Shults J
    Cancer Invest; 2005; 23(4):296-302. PubMed ID: 16100941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gefitinib plus docetaxel in non-small-cell lung cancer.
    Costa DB; Kobayashi S
    Lancet; 2009 Feb; 373(9663):541; author reply 542. PubMed ID: 19217979
    [No Abstract]   [Full Text] [Related]  

  • 24. Gefitinib plus docetaxel in non-small-cell lung cancer.
    Zalcman G; Bergot E
    Lancet; 2009 Feb; 373(9663):541; author reply 542. PubMed ID: 19217981
    [No Abstract]   [Full Text] [Related]  

  • 25. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
    Borghaei H; Paz-Ares L; Horn L; Spigel DR; Steins M; Ready NE; Chow LQ; Vokes EE; Felip E; Holgado E; Barlesi F; Kohlhäufl M; Arrieta O; Burgio MA; Fayette J; Lena H; Poddubskaya E; Gerber DE; Gettinger SN; Rudin CM; Rizvi N; Crinò L; Blumenschein GR; Antonia SJ; Dorange C; Harbison CT; Graf Finckenstein F; Brahmer JR
    N Engl J Med; 2015 Oct; 373(17):1627-39. PubMed ID: 26412456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gefitinib: a review of its use in the management of advanced non-small-cell lung cancer.
    Frampton JE; Easthope SE
    Drugs; 2004; 64(21):2475-92. PubMed ID: 15482004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reasons for response differences seen in the V15-32, INTEREST and IPASS trials.
    Saijo N; Takeuchi M; Kunitoh H
    Nat Rev Clin Oncol; 2009 May; 6(5):287-94. PubMed ID: 19390555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets.
    Cohen MH; Williams GA; Sridhara R; Chen G; McGuinn WD; Morse D; Abraham S; Rahman A; Liang C; Lostritto R; Baird A; Pazdur R
    Clin Cancer Res; 2004 Feb; 10(4):1212-8. PubMed ID: 14977817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer.
    Paz-Ares L; Ross H; O'Brien M; Riviere A; Gatzemeier U; Von Pawel J; Kaukel E; Freitag L; Digel W; Bischoff H; García-Campelo R; Iannotti N; Reiterer P; Bover I; Prendiville J; Eisenfeld AJ; Oldham FB; Bandstra B; Singer JW; Bonomi P
    Br J Cancer; 2008 May; 98(10):1608-13. PubMed ID: 18475293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.
    Natale RB; Bodkin D; Govindan R; Sleckman BG; Rizvi NA; Capó A; Germonpré P; Eberhardt WE; Stockman PK; Kennedy SJ; Ranson M
    J Clin Oncol; 2009 May; 27(15):2523-9. PubMed ID: 19332730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gefitinib (Iressa) in metastatic patients with non-small cell lung cancer: preliminary experience in a Brazilian center.
    del Giglio A; Ito C
    Sao Paulo Med J; 2004 May; 122(3):128-30. PubMed ID: 15448812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gefitinib: a new antineoplastic for advanced non-small-cell lung cancer.
    Cersosimo RJ
    Am J Health Syst Pharm; 2004 May; 61(9):889-98. PubMed ID: 15156965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study.
    Chang A; Parikh P; Thongprasert S; Tan EH; Perng RP; Ganzon D; Yang CH; Tsao CJ; Watkins C; Botwood N; Thatcher N
    J Thorac Oncol; 2006 Oct; 1(8):847-55. PubMed ID: 17409969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gefitinib plus docetaxel in non-small-cell lung cancer.
    Singh N; Aggarwal AN
    Lancet; 2009 Feb; 373(9663):541-2; author reply 542. PubMed ID: 19217980
    [No Abstract]   [Full Text] [Related]  

  • 35. [Predictive factors for response and survival of gefitinib-treated locally advanced or metastatic non-small cell lung cancer patients: a retrospective analysis of two phase II clinical trials].
    Zhao YY; Zhang Y; Zhao HY; Wu JX; Jiang W; Xue C; Zhang L
    Ai Zheng; 2009 Jun; 28(6):626-31. PubMed ID: 19635201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.
    Simon GR; Ruckdeschel JC; Williams C; Cantor A; Chiappori A; Rocha Lima CM; Antonia S; Haura E; Wagner H; Robinson L; Sommers E; Alberts M; Bepler G
    Cancer Control; 2003; 10(5):388-95. PubMed ID: 14581894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of gefitinib in the management of Asian patients with non-small cell lung cancer.
    Chang AY
    Expert Opin Investig Drugs; 2008 Mar; 17(3):401-11. PubMed ID: 18321238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gefitinib (Iressa) trials in non-small cell lung cancer.
    Johnson DH
    Lung Cancer; 2003 Aug; 41 Suppl 1():S23-8. PubMed ID: 12867059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gefitinib in the treatment of advanced non-small-cell lung cancer].
    Zhang L; Yu SY
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):539-41. PubMed ID: 17147123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: a meta-analysis.
    Chang CH; Chen KY; Young-Xu Y; Kurth T; Orav EJ; Yang PC; Chan KA
    Lung Cancer; 2008 Nov; 62(2):242-52. PubMed ID: 18423782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.